These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32779670)
1. Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancer. Zhang M; Zhang X; Cai S; Mei H; He Y; Huang D; Shi W; Li S; Cao J; He B J Mater Chem B; 2020 Sep; 8(35):7931-7940. PubMed ID: 32779670 [TBL] [Abstract][Full Text] [Related]
2. Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy. Xie Q; Gao S; Tian R; Wang G; Qin Z; Chen M; Zhang W; Wen Q; Ma Q; Zhu L Int J Nanomedicine; 2023; 18():1-16. PubMed ID: 36632237 [TBL] [Abstract][Full Text] [Related]
3. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy. Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242 [TBL] [Abstract][Full Text] [Related]
4. Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy. Yue C; Zhang C; Alfranca G; Yang Y; Jiang X; Yang Y; Pan F; de la Fuente JM; Cui D Theranostics; 2016; 6(4):456-69. PubMed ID: 26941840 [TBL] [Abstract][Full Text] [Related]
5. CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells. Yoon J; Kim H; Jeong YI; Yang HS Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408970 [TBL] [Abstract][Full Text] [Related]
6. Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer. Yu TT; Peng XC; Wang MF; Han N; Xu HZ; Li QR; Li LG; Xu X; Ma QL; Liu B; Wang J; Zhao L; Chen X; Li TF J Cancer Res Clin Oncol; 2022 Apr; 148(4):867-879. PubMed ID: 34997349 [TBL] [Abstract][Full Text] [Related]
7. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy. Sun CY; Zhang BB; Zhou JY J Mater Chem B; 2019 Aug; 7(31):4843-4853. PubMed ID: 31389968 [TBL] [Abstract][Full Text] [Related]
8. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy. Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment. Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383 [TBL] [Abstract][Full Text] [Related]
10. Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy. Ren Q; Liang Z; Jiang X; Gong P; Zhou L; Sun Z; Xiang J; Xu Z; Peng X; Li S; Li W; Cai L; Tang J Int J Biol Macromol; 2019 Jun; 130():845-852. PubMed ID: 30844454 [TBL] [Abstract][Full Text] [Related]
11. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment. Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046 [TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Yoon HY; Koo H; Choi KY; Lee SJ; Kim K; Kwon IC; Leary JF; Park K; Yuk SH; Park JH; Choi K Biomaterials; 2012 May; 33(15):3980-9. PubMed ID: 22364699 [TBL] [Abstract][Full Text] [Related]
13. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer. Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335 [TBL] [Abstract][Full Text] [Related]
14. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy. Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024 [TBL] [Abstract][Full Text] [Related]
15. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers. Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295 [TBL] [Abstract][Full Text] [Related]
16. CD44 Receptor-Specific and Redox-Sensitive Nanophotosensitizers of Hyaluronic Acid-Chlorin e6 Tetramer Having Diselenide Linkages for Photodynamic Treatment of Cancer Cells. Kim DM; Shim YH; Kwon H; Kim JP; Park JI; Kim DH; Kim DH; Kim JH; Jeong YI J Pharm Sci; 2019 Nov; 108(11):3713-3722. PubMed ID: 31394112 [TBL] [Abstract][Full Text] [Related]
17. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer. Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921 [TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593 [TBL] [Abstract][Full Text] [Related]
19. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor. Yang X; Shi X; Ji J; Zhai G Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticulate photosensitizer decorated with hyaluronic acid for photodynamic/photothermal cancer targeting therapy. Wang X; Ouyang X; Chen J; Hu Y; Sun X; Yu Z Nanomedicine (Lond); 2019 Jan; 14(2):151-167. PubMed ID: 30511886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]